Diabetes During Pregnancy
Diabetes During Pregnancy
Diabetes During Pregnancy
pregnancy
Submitted by : Sherlyn Guialoden
Erwin M. Gregorio
Submitted Mrs. Princess Catalua
Arandilla RN,RM
Introduction
Diabetes is a endocrinological disorder.
The prevalence of diabetes is about
3% in the whole population.
the characteristics of diabetes is
elevated plasma glucose levels.
Pathophysiology -insulin
The glucose metabolism is mainly
controlled by insulin.
The insulin is secreted by pancreatic cell.
The insulin promote the glucose
metabolism in tissues throughout the body.
As the blood glucose is utilized, the blood
glucose levels would be lowered.
Pathophysiology -Insulin
sensitivity
In two conditions, the blood glucose will be
elevated.
One is the insufficient insulin secretion by
beta cells.
The other is the decreased insulin activity.
The insulin activity is called as the insulin
sensitivity.
Pathophysiology
placenta(1)
The placenta can secrete a variety of
hormones.
These hormones include estrogen,
progesterone, cortisol, human placental
lactogen, human chorionic gonadotropin, etc.
The hormones produced by placenta antagonize
the effects of insulin.
It is estimated that the insulin sensitivity will be
decreased by 40% in the 3rd trimester.
Pathophysiology-placenta(2)
The decreased insulin sensitivity is
the key for the mechanism of GDM.
For GDM, there are no placental
hormones after delivery of placenta,
so the insulin sensitivity and the
blood glucose levels would be
restored to the normal.
Classification
Pregestational or overt: be diagnosed
before pregnancy.
Gestational diabetes Mellitus(GDM) : be
diagnosed during pregnancy.
GDM is more common than the overt
diabetes.
Gestational diabetes
mellitus
Definition: any degree carbohydrate intolerance
with onset or first recognition during pregnancy.
GDM is more common than the overt diabetes.
The GDM account for more than 90% of the
whole diabetes during pregnancy.
GDM could contain some pregestaional diabetes.
The congenital
malformation
The overt diabetes is related to the
pregestational daibetes.
The incidence of the congenital
malformation is not elevated in GDM
women.
Macrosomia
Glucose can cross the placenta.
The Maternal hyperglycemia can
cause the fetal hyperglycemia.
The hyperglycemia would stimulate
the growth of fetus, then macrosomia
will occur.
Hydramnios
Although diabetic pregnancies are often
complicated by hydramnios, the cause is unclear.
A likely explanation is that fetal hyperglycemia
causes polyuria. In a study from Parkland
Hospital, Dashe and co-workers (2000) found that
the amnionic fluid index parallels the amnionic
fluid glucose level among women with diabetes.
This finding suggests that the hydramnios
associated with diabetes is a result of increased
amnionic fluid glucose concentration.
Hypoglycemia
The fetus produces its own insulin to
modulate its blood glucose.
The hyperinsulinemia will occur in response
to the hyperglycemia in the fetus.
After delivery, the blood glucose provided
by mother will be stopped, but the insulin
production would not be reduced, so the
hyperglycemia will results in the newborns.
Respiratory distress
syndrome
The newborn respiratory distress
syndrome is related to the fetal lung
immaturity.
Hyperinsulinemia inhibits fetal lung
maturity.
So diabetes can result in the
respiratory distress syndrome.
Preeclampsia
Preeclampsia is related to glucose
control .
Hypertension that is induced or
exacerbated by pregnancy is the
major complication that most often
forces preterm delivery in diabetic
women.
Distocia
Distocia is associated with
macrosomia.
Should distocia can results into
serious birth trauma.
Ketoacidosis
Although it affects only approximately 1
percent of diabetic pregnancies, ketoacidosis
remains one of the most serious
complication .
The incidence of fetal loss is about 20
percent with ketoacidosis .
Pregnant women usually have ketoacidosis
with lower blood glucose levels than when
nonpregnant.
Screening
Most patients with GDM have normal
fasting glucose levels.
The challenge of glucose tolerance
must be done for most cases with
GDM.
Screening strategy
In our country, every pregnant
woman is advised to do OGTT at
about 24 weeks of gestation.
If the GDM symptoms are present
after 24 weeks, the OGTT should be
done again.
Antepartum Management
There is a consensus that once diabetes is
diagnosed, the treatment should be
recommended for diabetes during pregnancy.
The goals of treatment are to prevent
macrosomia, avoid ketosis, and detect
pregnancy complications (eg, hypertension,
intrauterine growth restriction, and fetal
distress).
The management includes diet, exercise and
insulin.
Diet therapy
The goals of diet therapy in GDM are to avoid
ketosis, achieve normal blood glucose levels, obtain
proper nutrition, and gain weight appropriately.
The amount and distribution of carbohydrate should
be based on clinical outcome measures (eg, hunger,
blood glucose levels, weight gain), but a minimum of
175 g of carbohydrate per day should be provided.
Exercise
Experts recommend that women with
GDM should exercise regularly to
control blood glucose levels.
but an improvement in clinical
outcomes has not been
demonstrated from compliance with
this recommendation.
Insulin therapy
Traditionally, insulin is used if dietary
management does not maintain blood
glucose at normal levels.
Insulin may be initiated at 0.7 U/kg actual body
weight/d given in divided dosages: two-thirds of
the daily dosage before breakfast and the
remainder of the dosage before dinner.
Insulin therapy require close monitoring and
adjustment based on blood glucose levels,
meal choices, and activity levels.
Obstetrics management(1)
The goal of intrapartum GDM management is
to avoid operative delivery, shoulder dystocia,
birth trauma, and neonatal hypoglycemia.
For patients who have maintained excellent
control of blood glucose levels with diet and
exercise, delivery is recommended at 40
weeks.
For patients with medication-requiring GDM,
induction at 38 to 39 weeks gestation is
recommended
Obstetrics management(2)
In general, women with gestational
diabetes who do not require insulin
seldom require early delivery or other
interventions.
Elective cesarean delivery to avoid
brachial plexus injuries in macrosomic
infants is an important issue.
Postpartum management(1)
In most women with GDM,
hyperglycemia rapidly resolves
shortly after delivery.
It is reasonable to measure a single
random or fasting blood glucose level
before discharge from the hospital.
Postpartum management(2)
Postpartum glucose tolerance testing is important
for women who had GDM.
Women with GDM have a 7-fold increased risk of
developing type 2 diabetes mellitus compared with
those who had a normoglycemic pregnancy.
At 6 to 12 weeks postpartum, only one-third of
women with persistent glucose intolerance have an
abnormal fasting blood glucose level.
Therefore, to detect all women with glucose
intolerance, a 75-g, fasting, 2-hour, oral glucose
tolerance test is recommended.